SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-004684
Filing Date
2023-01-24
Accepted
2023-01-24 18:33:10
Documents
1
Period of Report
2023-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12191
  Complete submission text file 0001209191-23-004684.txt   13580
Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
White William Richard (Reporting) CIK: 0001778739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 23549309

Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations